| Bioactivity | PLP (190-209) is a myelin proteolipid protein (PLP) fragment. PLP (190-209) is used to induce experimental autoimmune encephalomyelitis (EAE) animal models for multiple sclerosis research[1]. |
| CAS | 165549-59-7 |
| Sequence | Ser-Lys-Thr-Ser-Ala-Ser-Ile-Gly-Ser-Leu-Cys-Ala-Asp-Ala-Arg-Met-Tyr-Gly-Val-Leu |
| Shortening | SKTSASIGSLCADARMYGVL |
| Formula | C85H144N24O29S2 |
| Molar Mass | 2030.33 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Muller DM, et al. A neuropathological analysis of experimental autoimmune encephalomyelitis with predominant brain stem and cerebellar involvement and differences between active and passive induction. Acta Neuropathol. 2000 Aug;100(2):174-82. |
PLP (190-209)
CAS: 165549-59-7 F: C85H144N24O29S2 W: 2030.33
PLP (190-209) is a myelin proteolipid protein (PLP) fragment. PLP (190-209) is used to induce experimental autoimmune en
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.